I have used three payment routes and the only thing that changed with each was how much leverage I had when something went wrong.
The question I want answered is how people are thinking about the trade-off between reversibility and privacy, because you cannot have both.
If the honest answer is that nobody knows, that is a useful answer and I would rather have it.
Short answer first, then the reasoning. Start from the measurement rather than the conclusion. Almost every disagreement here turns out to be two people measuring different things and comparing the numbers anyway.
Dr.SleepRoch said:Start from the measurement rather than the conclusion.
That is right, and it stops being right at the edges. The general case is well behaved; the interesting cases in this thread are all at the boundary where the general case breaks.
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View Resultsjason_paloalto said:I have used three payment routes and the only thing that changed with each was how much leverage I had when something went wrong.
Same pattern here, and in the same order.
Adding the clinical framing, because it changes how the question reads. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.
That is the short version; the long version is somebody else's post.